在最新签署的CEPI合作协议框架下,Moderna公司作出明确承诺——将以可及定价向中低收入国家提供至少50万剂mRNA-1469疫苗。此举不仅彰显了企业在全球公共卫生领域的责任担当,更意味着该创新型疫苗有望加速惠及资源匮乏地区的脆弱人群。通过这一协议,Moderna旨在平衡商业利益与公平获取,确保疫苗供应链的韧性与可负担性。
在最新签署的CEPI合作协议框架下,Moderna公司作出明确承诺——将以可及定价向中低收入国家提供至少50万剂mRNA-1469疫苗。此举不仅彰显了企业在全球公共卫生领域的责任担当,更意味着该创新型疫苗有望加速惠及资源匮乏地区的脆弱人群。通过这一协议,Moderna旨在平衡商业利益与公平获取,确保疫苗供应链的韧性与可负担性。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.